Skip to main content
Caplight Logo









Yuzu Health

Yuzu Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://yuzu.health/

Last Round

Series A

Apr 6, 2026

Total Funding Raised

$40M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Yuzu Health is a healthcare technology company that provides a third-party administrator (TPA) platform for businesses to create and manage their own health insurance plans.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Revenue Cycle, EHR & EMR, Workflow Automation

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

third-party administratorTPAvalue-based carerevenue cycle managementpractice management softwareclaims processinghealth techvertical SaaSclaims adjudicationprimary care platformworkflow automationPMPM billinghealth plan administrationhealthcare infrastructureadmin tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yuzu Health Comparables

Compare Yuzu Health with similar companies based on industry and business-model similarity.

Yuzu Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elation Health
81%
Aledade
76%
athenahealth
66%

Yuzu Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 6, 2026
SeedOct 31, 2023

Key People

Founding team and executive leadership

Max Kauderer

Co-Founder CEO

Founding Team

Yuzu Health Investors

Notable investors and investment history

Yuzu Health investors
InvestorRounds
CoalitionSeed
NeoSeed, Series A
Timeless VenturesSeries A
Browder CapitalSeed
Timeless VenturesSeries A
Chemistry VCSeries A
General CatalystSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 32% QoQ, from 82 to 108 employees.

  • Jul 18, 2026

    Grew 37% QoQ, from 71 to 97 employees.

Yuzu Health Filings

Explore SEC and related filing metadata, where available.

Yuzu Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Yuzu Health's valuation, stock price, and market status.

Is Yuzu Health a public or private company?

Yuzu Health is a private company.

What is the current stock price of Yuzu Health?

Yuzu Health is a private company with no public stock price. No recent secondary market data is available.

How much is Yuzu Health worth (valuation)?

Valuation information for Yuzu Health is not publicly available.

Can I buy Yuzu Health stock?

Yuzu Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Yuzu Health's last funding round?

Yuzu Health's most recent funding round was Series A on April 6, 2026.

Who are the main investors in Yuzu Health?

Key investors in Yuzu Health include Chemistry VC, General Catalyst.

Will Yuzu Health IPO soon?

No public IPO plans have been announced for Yuzu Health.

How can I track Yuzu Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yuzu Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range86
Year Founded2022
Last FundingApr 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?